COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 2524: Articles 25231-25240  | Next

Associations between state-level healthcare access and COVID-19 case trajectories in the United States
Liu, S. H., Liu, B., Norbury, A., Li, Y.
10.1101/2020.07.04.20146100 — Posted: 2020-07-06
Chloroquine and Hydroxychloroquine for the treatment of COVID-19: A Systematic Review and Meta-analysis
Elavarasi, A., Prasad, M., Seth, T., Sahoo, R. K., Madan, K., Nischal, N., Soneja, M., Sharma, A., Maulik, S. K., Shalimar, , Garg, P.
10.1101/2020.07.04.20146381 — Posted: 2020-07-06 Discussion: Onsite
Prevalence of HIV in patients hospitalized for COVID-19 and associated outcomes: a systematic review and meta-analysis
Ssentongo, P., Heilbrunn, E. S., Ssentongo, A. E., Advani, S., Chinchilli, V. M., Nunez, J. J., Du, P.
10.1101/2020.07.03.20143628 — Posted: 2020-07-06
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Franke, C., Ferse, C., Kreye, J., Reincke, M., Sanchez-Sendin, E., Rocco, A., Steinbrenner, M., Angermair, S., Treskatsch, S., Zickler, D., Eckardt, K.-U., Dersch, R., Hosp, J., Audebert, H. J., Endres, M., Ploner, C. J., Pruess, H.
10.1101/2020.07.01.20143214 — Posted: 2020-07-06
Study of the Dependence of Effective Reproduction Number of COVID-19 on the Temperature and Humidity: A Case Study with the Indian States
Mandal, M., Patra, S., Pal, S., Acharya, S., Hazra, M.
10.1101/2020.07.05.20146324 — Posted: 2020-07-06
Explainable death toll motion modeling: COVID-19 narratives and counterfactuals
Veloso, A., Ziviani, N.
10.1101/2020.07.04.20146423 — Posted: 2020-07-06
The UK Covid-19 lockdown weakened in April and May 2020: implications for the size of the epidemic and for outcomes had lockdown been earlier
Lander, A. D.
10.1101/2020.07.04.20146340 — Posted: 2020-07-06
Evaluation of Viasure SARS-CoV-2 RT-qPCR kit (CerTest Biotec) using CDC FDA EUA RT-qPCR kit as a gold standard.
Freire-Paspuel, B., Vega-Marino, P. A., Velez, A., Cruz, M., Perez, F., Garcia Bereguiain, M. A.
10.1101/2020.06.29.20131367 — Posted: 2020-07-06
Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist
Nath, H., Mallick, A., Roy, S., Sukla, S., Basu, K., De, A., Biswas, S.
10.1101/2020.07.03.20145797 — Posted: 2020-07-06 Discussion: Onsite
Sample Pooling as an efficient strategy for SARS-COV-2 RT-PCR screening: a multicenter study in Spain
de Salazar, A., Aguilera, A., Trastoy, R., Fuentes, A., Alados, J. C., Causse, M., Galan, J. C., Moreno, A., Trigo, M., Perez, M., Roldan, C., Pena, M. J., Bernal, S., Serrano-Conde, E., Barbeito, G., Torres, E., Riazzo, C., Cortes-Cuevas, J. L., Chueca, N., Coira, A., Sanchez-Calvo, J. M., Marfil, E., Becerra, F., Gude, M. J., Pallares, A., Perez del Molino, M. L., Garcia, F.
10.1101/2020.07.04.20146027 — Posted: 2020-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).